Biopsy | Surviving Mesothelioma

Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients

A team of French scientists believe they have found a way to predict survival and help plan a treatment course for people with the epithelioid form of malignant pleural mesothelioma. Until now, mesothelioma histological subtype has been the only way to reliably predict mesothelioma prognosis based on pathology (cellular characteristics that can be seen under a microscope). But mesothelioma researchers at the University Hospital of … Continue reading Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients »

Mesothelioma Diagnosis: Fluid Cytology Versus Biopsy

A mesothelioma diagnosis using pleural fluid is just as reliable at predicting survival as a diagnosis based on a tissue sample. That conclusion, published in a recent issue of the British Journal of Cancer, is based on an analysis of more than 2,000 cases of malignant mesothelioma over 42 years. Researchers from the University of Western Australia and Curtin University in Perth compared the survival … Continue reading Mesothelioma Diagnosis: Fluid Cytology Versus Biopsy »

New Mesothelioma Grading System May Lead to More Accurate Prognosis

A new method for determining the prognosis of people with peritoneal mesothelioma suggests that patients whose mesothelioma cells have certain characteristics may live as long as 12 years. A research team including scientists from Wake Forest Baptist Health in North Carolina, the University of Mississippi Medical Center, and Memorial Sloan Kettering Cancer Center in New York has developed the first two-tier grading system for malignant … Continue reading New Mesothelioma Grading System May Lead to More Accurate Prognosis »

Mesothelioma Subtype Unrelated to Source or Degree of Asbestos Exposure

The source or degree of a mesothelioma patient’s asbestos exposure does not appear to have a direct impact on what mesothelioma subtype they develop. That is according to the results of a newly-published study out of Australia, a country with one of the world’s highest rates of asbestos cancer. To make their determination, mesothelioma researchers reviewed malignant mesothelioma cases from the Western Australian Mesothelioma Registry … Continue reading Mesothelioma Subtype Unrelated to Source or Degree of Asbestos Exposure »

Diagnosing Mesothelioma with Medical Thoracoscopy

Medical thoracoscopy, a procedure used to diagnose and treat pleural diseases such as malignant pleural mesothelioma, provides the information needed to make a diagnosis in about 80 percent of patients. That is up by more than 20 percent in the last three decades. In a newly published study, a team of Italian pulmonary medicine specialists say the procedure, which is also known as pleuroscopy, has … Continue reading Diagnosing Mesothelioma with Medical Thoracoscopy »

Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention

Preventive radiotherapy may not be the best way to keep new tumors from growing at the site of pleural interventions in people with malignant pleural mesothelioma. That is the finding of a group of physician researchers in the UK, who tracked the outcomes of more than 200 mesothelioma patients from institutes across the country who had procedures that required the use of a large-bore pleural … Continue reading Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention »

Preventing New Tumor “Seeding” After Mesothelioma Biopsy

Doctors in England are testing a method they hope will reduce the likelihood of pleural mesothelioma patients developing new tumors in their chest wall after a biopsy. A tissue sample is required to make a definitive mesothelioma diagnosis. But as many as 15 percent of mesothelioma patients who undergo some kind of invasive biopsy procedure will develop tiny new tumors along the tracks of the … Continue reading Preventing New Tumor “Seeding” After Mesothelioma Biopsy »

The Challenge of Diagnosing Malignant Mesothelioma

The case of a Japanese man whose mesothelioma went undetected until it claimed his life seven months later highlights the need for better and earlier mesothelioma diagnosis. The man is the subject of a new article published in the medical journal Case Reports in Oncology. Although the patient complained of chest pain for months, his doctors were never able to make a diagnosis of mesothelioma. … Continue reading The Challenge of Diagnosing Malignant Mesothelioma »

Mesothelioma Research Gets a Boost From New Tissue Bank

A new biobank of mesothelioma cell samples in the UK is set to help advance mesothelioma research around the world. The recently-opened mesothelioma tissue bank, called MesobanK UK, will be an international resource of cells specifically for use in mesothelioma research. Mesothelioma Cell Samples and More When the biobank is complete within the next few years, it is expected to contain samples of tissue, blood … Continue reading Mesothelioma Research Gets a Boost From New Tissue Bank »

Lung Fluid Versus Tissue Biopsy for Mesothelioma Diagnosis

Testing for certain biomarkers in lung fluid may offer a reliable way to help diagnose malignant mesothelioma, even without a tissue biopsy. Diagnosing mesothelioma from lung fluid alone is controversial. But pathology researchers in Seattle and Vancouver compared mesothelioma biomarkers BAP1 and p16 in lung fluid and tissue samples in 15 mesothelioma patients and got nearly identical results. Lung Fluid vs. Biopsy – Which was … Continue reading Lung Fluid Versus Tissue Biopsy for Mesothelioma Diagnosis »

Get your free copy of
“Surviving Mesothelioma” Today!